Özlem Özkul

Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?

Osman Köstek, Muhammet Bekir Hacıoğlu, Abdullah Sakin et al. · Cancer Chemotherapy and Pharmacology · 2018 · 33 citations

Oncology, Colorectal Cancer, Metastatic Colorectal Cancer +7

A study on basic demographic and disease characteristics of cancer-diagnosed Syrian refugees treated in the border city of Turkey, Sanliurfa; a hospital-based retrospective case series study.

Bakkal Temi Y, Murat Sedef A, Serkan Gökçay et al. · PubMed · 2019 · 22 citations

Are there any differences among psoriasis, psoriatic arthritis and rheumatoid arthritis in terms of metabolic syndrome and cardiovascular risk factors?

Özlem Özkul, Duygu Temiz Karadağ, Özlem Özdemir Işık et al. · European Journal of Rheumatology · 2019 · 17 citations · Full text

Protective effect of oxytocin through its anti-inflammatory and antioxidant role in a model of sepsis-induced acute lung injury: Demonstrated by CT and histological findings

İbrahim Halil Sever, Bahattin Özkul, D. Erisik Tanriover et al. · Experimental Lung Research · 2021 · 16 citations

Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group

Mustafa Gürbüz, Yasin Kutlu, Erman Akkuş et al. · Journal of Cancer Research and Clinical Oncology · 2022 · 12 citations · Full text